Brief: Janux Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results

Janux Therapeutics

10/03/2023 21:47

March 10 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
    * JANUX THERAPEUTICS INC - AS OF DECEMBER 31, 2022, JANUX
REPORTED
CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $327.0
MILLION
    * JANUX THERAPEUTICS INC - JANUX ANTICIPATES PROVIDING AN
INTERIM
CLINICAL UPDATE FROM PSMA-TRACTR (JANX007) TRIAL IN SECOND HALF
OF 2023

Source text for Eikon:  ID:nBw77kjr7a 
Further company coverage:  JANX.O 

 ((Reuters.Briefs@thomsonreuters.com;))